Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study. [electronic resource]
Producer: 20161006Description: 42 p. digitalISSN:- 1475-2875
- Adolescent
- Adult
- Aged
- Antimalarials -- adverse effects
- Chloroquine -- adverse effects
- Drug Therapy, Combination
- Female
- Heterocyclic Compounds, 1-Ring -- adverse effects
- Humans
- Malaria -- drug therapy
- Malaria, Vivax -- drug therapy
- Male
- Maleates -- adverse effects
- Middle Aged
- Peroxides -- adverse effects
- Quinolines -- adverse effects
- Spiro Compounds -- adverse effects
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.